September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
The third country worldwide to approve this medication for HCC in combination with Durvalumab – Prof.Humaid Al-Shamsi
Jun 12, 2023, 03:13

The third country worldwide to approve this medication for HCC in combination with Durvalumab – Prof.Humaid Al-Shamsi

Last night in Dubai , in collaboration with AstraZeneca we successfully launched tremelimumab for the treatment of hepatocellular carcinoma (HCC). This remarkable achievement makes us the third country worldwide to approve this medication for HCC in combination with Durvalumab. Our unwavering commitment to providing the most advanced treatments for our patients in the UAE and the region remains steadfast.

Source: Prof.Humaid Al-Shamsi/Linkedin